Enterprise Account Executive - Michigan
CohesityFull Time
Mid-level (3 to 4 years), Senior (5 to 8 years)
Candidates should possess a B.S. in biology, life science, business, or marketing and have at least 1 year of applicable industry experience. Preferred qualifications include sales support experience in healthcare, preferably oncology or pathology, with a history of proven past performance, or general clinical experience. The ability to quickly learn genomic and oncology information, work independently, communicate proactively, manage multiple projects, prioritize tasks, and meet critical deadlines is essential. Excellent customer service skills, a positive attitude, strong administrative skills, and the capacity to manage business in complex environments are also required. Candidates must be able to travel throughout the territory as needed and demonstrate Tempus’ values by acting with integrity, respect, and trust.
The Clinical Account Associate will work with the Clinical Account Executive on plans for gaining and retaining clients, collaborating with sales positions to achieve company goals. They will identify opportunities with existing customers for Tempus algorithmic tests and add-ons, and collaborate on upsell opportunities for various products. Responsibilities include driving customer adoption of online ordering, identifying and developing partnering opportunities with prospective oncology clients, and promoting compliance with new web-based molecular information tools. The associate will analyze the competitive landscape, monitor sales performance, and develop a comprehensive business plan for the territory. They will build and maintain relationships with physicians, office staff, and pathology departments to drive clinical orders and ensure smooth specimen sendouts. This includes maintaining regular contact with targeted accounts, coordinating medical affairs report reviews, managing order kit and literature replenishment, attending approved local conferences, and obtaining necessary clinical data for Tempus-tested patients.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.